Factors influencing infection by pandemic influenza A (H1N1)pdm09 over three epidemic waves in Singapore

被引:14
作者
Chen, Mark I. C. [1 ,2 ,3 ]
Cook, Alex R. [1 ,2 ,3 ,4 ,5 ]
Lim, Wei Yen [1 ,2 ]
Lin, Raymond [6 ]
Cui, Lin [6 ]
Barr, Ian G. [7 ]
Kelso, Anne [7 ]
Chow, Vincent T. [8 ]
Leo, Yee Sin [1 ,2 ,3 ]
Hsu, Jung Pu [8 ]
Shaw, Rob [7 ]
Chew, Serene [3 ]
Yap, Joe Kwan [3 ]
Phoon, Meng Chee [8 ]
Koh, Hiromi W. L. [1 ,2 ]
Zheng, Huili [1 ,2 ]
Tan, Linda [1 ,2 ]
Lee, Vernon J. [1 ,2 ,3 ]
机构
[1] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
[3] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore
[4] Natl Univ Singapore, Yale NUS Coll, Singapore 117548, Singapore
[5] Duke NUS Grad Med Sch, Singapore, Singapore
[6] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore
[7] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia
[8] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Natl Univ Hlth Syst, Singapore 117595, Singapore
关键词
Epidemic waves; H1N1pdm09; haemagglutination inhibition; risk factors; seroconversion; seroepidemiology; HONG-KONG; H1N1; VIRUS; VACCINATION; HOUSEHOLD; MORTALITY; RESPONSES; ANTIBODY; COHORT;
D O I
10.1111/irv.12129
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction Previous influenza pandemics had second and on occasion third waves in many countries that were at times more severe than the initial pandemic waves. Objective This study aims to determine the seroepidemiology of successive waves of H1N1pdm09 infections in Singapore and the overall risks of infection. Methods We performed a cohort study amongst 838 adults, with blood samples provided upon recruitment and at 5 points from 2009 to 2011 and tested by haemagglutination inhibition (HI) with A/California/7/2009 (H1N1pdm09). Surveys on key demographic and clinical information were conducted at regular intervals, and associations between seroconversion and these variables were investigated. Results After the initial wave from June to September 2009, second and third waves occurred from November 2009 to February 2010 and April to June 2010, respectively. Seroconversion was 13.5% during the first wave and decreased to 6.2% and 6.8% in subsequent waves. Across the three waves, the elderly and those with higher starting HI titres were at lower risk of seroconversion, while those with larger households were at greater risk. Those with higher starting HI titres were also less likely to have an acute respiratory infection. Conclusions The second and third waves in Singapore had lower serological attack rates than the first wave. The elderly and those with higher HI titres had lower risk, while those in larger households had higher risk of seroconversion.
引用
收藏
页码:1380 / 1389
页数:10
相关论文
共 50 条
[31]   Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09 [J].
Bradley-Stewart, A. ;
Jolly, L. ;
Adamson, W. ;
Gunson, R. ;
Frew-Gillespie, C. ;
Templeton, K. ;
Aitken, C. ;
Carman, W. ;
Cameron, S. ;
McSharry, C. .
JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (01) :100-107
[32]   Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study [J].
Umbreen, Gulshan ;
Rehman, Abdul ;
Avais, Muhammad ;
Jabeen, Chanda ;
Sadiq, Shakera ;
Maqsood, Rubab ;
Bin Rashid, Hamad ;
Afzal, Saira ;
Chaudhry, Mamoona .
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[33]   Patients with influenza A (H1N1 )pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC [J].
Marin-Corral, J. ;
Climent, C. ;
Munoz, R. ;
Samper, M. ;
Dot, I ;
Vila, C. ;
Masclans, J. R. ;
Rodriguez, A. ;
Martin-Loeches, I ;
Alvarez-Lerma, F. .
MEDICINA INTENSIVA, 2018, 42 (08) :473-481
[34]   Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh [J].
Nasreen, Sharifa ;
Rahman, Mustafizur ;
Hancock, Kathy ;
Katz, Jacqueline M. ;
Goswami, Doli ;
Sturm-Ramirez, Katharine ;
Holiday, Crystal ;
Jefferson, Stacie ;
Branch, Alicia ;
Wang, David ;
Veguilla, Vic ;
Widdowson, Marc-Alain ;
Fry, Alicia M. ;
Brooks, W. Abdullah .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2017, 11 (05) :394-398
[35]   Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination [J].
Gefenaite, Giedre ;
Tacken, Margot ;
Bos, Jens ;
Stirbu-Wagner, Irina ;
Korevaar, Joke C. ;
Stolk, Ronald P. ;
Wolters, Bert ;
Bijl, Marc ;
Postma, Maarten J. ;
Wilschut, Jan ;
Nichol, Kristin L. ;
Hak, Eelko .
PLOS ONE, 2013, 8 (06)
[36]   Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome [J].
Alvarez-Lerma, Francisco ;
Marin-Corral, Judith ;
Vila, Clara ;
Ramon Masclans, Joan ;
Gonzalez de Molina, Francisco Javier ;
Martin Loeches, Ignacio ;
Barbadillo, Sandra ;
Rodriguez, Alejandro .
CRITICAL CARE, 2016, 20
[37]   Influenza A(H1N1)pdm09 infection and viral load analysis in patients with different clinical presentations [J].
Guimaraes Alves, Vitoria Rodrigues ;
Perosa, Ana Helena ;
de Souza Luna, Luciano Kleber ;
Cruz, Jessica Santiago ;
Conte, Danielle Dias ;
Bellei, Nancy .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2020, 115
[38]   Phylogenetic analyses of influenza A (H1N1)pdm09 hemagglutinin gene during and after the pandemic event in Brazil [J].
Resende, Paola Cristina ;
Motta, Fernando Couto ;
Born, Priscila Silva ;
Machado, Daniela ;
Caetano, Braulia Costa ;
Brown, David ;
Siqueira, Marilda Mendonca .
INFECTION GENETICS AND EVOLUTION, 2015, 36 :147-155
[39]   A study of an influenza A (H1N1)pdm09 outbreak in pregnant women in Rajasthan, India [J].
Agrawal, Abhishek ;
Agarwal, Sujata ;
Kumar, Vinay ;
Nawal, Chuttan L. ;
Mital, Pradeep ;
Chejara, Radheyshyam .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 132 (02) :146-150
[40]   Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09 [J].
Louie, Janice K. ;
Yang, Samuel ;
Acosta, Meileen ;
Yen, Cynthia ;
Samuel, Michael C. ;
Schechter, Robert ;
Guevara, Hugo ;
Uyeki, Timothy M. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (09) :1198-1204